Chest pain other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Line 23: Line 23:
! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF| Exercise ECG}}
! style="width: 200px; background: #4479BA;" | {{fontcolor|#FFF| Exercise ECG}}
! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Stress Nuclear}}
! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Stress Nuclear}}
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|400px}}
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|Stress Echocardiography}}
! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|500px}}
! style="width: 300px; background: #4479BA;" | {{fontcolor|#FFF|Stress CMR}}
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|600px}}
! style="width: 400px; background: #4479BA;" | {{fontcolor|#FFF|600px}}
|-
|-
Line 34: Line 34:
*Limited [[acoustic]] windows (in [[COPD]] [[patients]])
*Limited [[acoustic]] windows (in [[COPD]] [[patients]])
*Inability to reach target [[heart rate]]
*Inability to reach target [[heart rate]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 500px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Reduced [[GFR]] (<30 mL/min/1.73 m2)
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
|-
|-
Line 43: Line 43:
* Contraindications  to  [[vasodilator]] administration
* Contraindications  to  [[vasodilator]] administration
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |  Uncontrolled [[heart failure]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |  Uncontrolled [[heart failure]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 500px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |   Contraindications to [[vasodilator]] administration
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
|-
|-
Line 53: Line 53:
* High-risk  [[unstable  angina]], active [[ACS]] or [[AMI]] (<2 d)
* High-risk  [[unstable  angina]], active [[ACS]] or [[AMI]] (<2 d)
*  Serious  [[ventricular arrhythmia]] or high risk for [[arrhythmias]] attributable to [[QT prolongation]]
*  Serious  [[ventricular arrhythmia]] or high risk for [[arrhythmias]] attributable to [[QT prolongation]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 500px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Avoiding [[CMR]] in the presence of implanted device due to  producing artifact limiting scan quality interpretatrion
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
|-
|-
Line 63: Line 63:
*  [[Respiratory  failure]]
*  [[Respiratory  failure]]
*Severe [[COPD]], acute [[pulmonary embolism]], severe [[pulmonary hypertension]]
*Severe [[COPD]], acute [[pulmonary embolism]], severe [[pulmonary hypertension]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 500px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" |   Significant  [[claustrophobia]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
|-   
|-   
Line 74: Line 74:
*  Contraindications  to  [[dobutamine]] (if [[pharmacologic stress test]] needed)  
*  Contraindications  to  [[dobutamine]] (if [[pharmacologic stress test]] needed)  
* [[Atrioventricular block]],  uncontrolled [[atrial fibrillation]]
* [[Atrioventricular block]],  uncontrolled [[atrial fibrillation]]
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 500px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | [[Caffeine]] use within past 12 hours
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | The width of this column is 600px
|-   
|-   

Revision as of 07:23, 24 December 2021

Chest pain Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chest pain from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Chest Pain in Pregnancy

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chest pain other diagnostic studies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chest pain other diagnostic studies

CDC on Chest pain other diagnostic studies

Chest pain other diagnostic studies in the news

Blogs on Chest pain other diagnostic studies

to Hospitals Treating Chest pain other diagnostic studies

Risk calculators and risk factors for Chest pain other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Aisha Adigun, B.Sc., M.D.[3]

Overview

Invasive Coronary Angiography (ICA) is used to determine the presence and severity of a luminal obstruction of an epicardial coronary artery, including its location, length, and diameter, as well as coronary blood flow. ICA provides the characterization of high-grade obstructive stenosis and possibility for percutaneous or surgical revascularization. (IFR and FFR) provide physiologic characteristic of stenosis. Radiation exposure to the patient during an interventional procedure varied 4 to 10 mSv and is dependent on procedural duration and complexity. The spatial resolution of ICA is 0.3 mm; as such, it is impossible to visualize arterioles (diameter of 0.1 mm) that regulate myocardial blood flow. Coronary vascular functional studies can be performed during coronary angiography. In normal coronary angiography there may be evident abnormal coronary vascular function. Assessment of coronary microcirculation and coronary vasomotion by coronary function testing are reasonable.

Other Diagnostic Studies



Contraindications of stress test for diagnosis of acute chest pain

Exercise ECG Stress Nuclear Stress Echocardiography Stress CMR 600px
Reduced GFR (<30 mL/min/1.73 m2) The width of this column is 600px
Uncontrolled heart failure Contraindications to vasodilator administration The width of this column is 600px
Avoiding CMR in the presence of implanted device due to producing artifact limiting scan quality interpretatrion The width of this column is 600px
Significant claustrophobia The width of this column is 600px
Caffeine use within past 12 hours The width of this column is 600px
The width of this column is 500px The width of this column is 600px


The width of this column is 500px The width of this column is 600px

References